Insight

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Premium Report
Premium Report

Key Findings: Spain Pharmaceutical Market Overview

This report provides an analytical summary of the pharmaceutical market in Spain including socioeconomic and demographic trends, regulatory issues, generics and biosimilars, and pharmaceutical market and pharmaceutical company infrastructure.

Published By Scrip Insights
26 Oct 2012 $1900
Buy
Premium Report
Premium Report

Key Findings: Product Launch Strategies

Pharma companies are increasingly competing on their ability to successfully launch products and manage the lifecycle of their products. The report reviews lessons from 10 case studies of launches.

Published By Scrip Insights
19 Oct 2012 $1910
Buy
Premium Report
Premium Report

Key Findings: Micro and Nano Technologies for Point-of-Care Testing

Micro and nanotechnologies are set to transform point-of-care diagnostics. Miniaturization of testing methods, advances in lab-on-a-chip microfluidic methodologies, improvements in detection technologies and novel biosensors are leading the way.

Published By Scrip Insights
15 Oct 2012 $1910
Buy
Premium Report
Premium Report

Progress in Target Validation

High Phase II attrition is hampering the pharma industry’s ability to reach sustainable rates of innovation. More rigorous validation of new biological targets prior to clinical development is essential for increasing R&D efficiency.

Published By Scrip Insights
28 Sep 2012 $2875
Buy
Premium Report
Premium Report

Key Findings: Pharmaceutical Diversification Trends 2012

A summary of the main diversification strategies used by pharma companies, in addition to the merger, acquisition, and divestment history of the top 10 companies, which have been instrumental in shaping the industry’s current business model.

Published By Scrip Insights
28 Sep 2012 $1910
Buy
Premium Report
Premium Report

Key Findings: Brazil Pharmaceutical Market Overview

This report provides an analytical summary of the pharmaceutical market in Brazil including socioeconomic and demographic trends, regulatory issues, generics and biosimilars, and pharmaceutical market and pharmaceutical company infrastructure.

Published By Scrip Insights
27 Sep 2012 $1910
Buy
Premium Report
Premium Report

Advances in Delivery to the Central Nervous System

CNS drugs are associated with longer development times and higher attrition rates than drugs for other therapy areas. Advances in delivery technologies are essential if the pursuit of novel treatments is to remain commercially viable.

Published By Scrip Insights
31 Aug 2012 $2875
Buy
Premium Report
Premium Report

Initiating Rare Disease Drug Discovery Projects

Favorable legislation and recent commercial successes have stimulated growing interest in the discovery of novel orphan drugs. However, there are many strategic considerations that are peculiar to the R&D process for diseases of low prevalence.

Published By Scrip Insights
28 Aug 2012 $2875
Buy
Premium Report
Premium Report

Optimization of Comparative Efficacy Trials

Comparative efficacy data are not necessarily required for approval but are increasingly demanded by payers. Meeting the expectations of all stakeholders can be challenging, making comparator selection and trial design complex decisions.

Published By Scrip Insights
06 Aug 2012 $2875
Buy
Premium Report
Premium Report

The Future of R&D Outsourcing

Industry pressures are impacting on both pharma sponsors and CROs, prompting them to evolve the way they contract and engage. Outsourced R&D also increasingly spans the full range of the value chain creating a developing market for contract services.

Published By Scrip Insights
18 Jul 2012 $2875
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.